These final results, together with a former report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the idea of targeting ACKR3 as a unique technique to modulate the opioid system, which could open new therapeutic avenues for opioid-linked Issues. In reaction to this difficulty, https://clivey702zvs1.jts-blog.com/profile